Swiss Market Ends Weak After Cautious Session

RTTNews | Pred 632 dňami
Swiss Market Ends Weak After Cautious Session

(RTTNews) - The Switzerland stock market ended weak on Friday after swinging between gains and losses in a tight band amid cautious moves by investors.

The benchmark SMI ended with a loss of 26.34 points or 0.24% at 11,128.24. The index touched a low of 11,110.80 and a high of 11,178.04 in the session.

Alcon drifted down 2.62% and Lonza Group ended lower by 2.36%. Sika, Novartis and Swisscom closed down by 1.1 to 1.2%. Geberit, SGS and Richemont lost 0.8 to 1%.

Roche Holding gained 1.56%. The drug maker announced it has received approval from the U.S. FDA for its Xofluza drug to treat influenza in children.

Credit Suisse climbed about 1.8%. UBS Group advanced 1.2%, Swiss Re gained 0.8% and Swiss Life Holding moved up 0.6%, while Holcim and Givaudan closed with modest gains.

In the Swiss Mid Price Index, Temenos Group, Galenica Sante, Kuehne & Nagel, Lindt & Spruengli Part, Lindt & Spruengli N, VAT Group, SIG Combibloc, Schindler Holding, Tecan Group and Schindler Ps lost 2 to 3.5%.

Bachem Holding rallied 2.75%. Adecco, Clariant and Georg Fischer ended modestly higher.

read more
Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Squibb Co. (BMY) announced Monday that the European Medicines Agency (EMA) has validated its Type II variation application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC).
RTTNews | Pred 4 h 20 min
Bay Street Likely To Open On Firm Note

Bay Street Likely To Open On Firm Note

Higher Canadian and U.S. futures, and rising crude oil and bullion prices point to a positive start on Bay Street Monday morning. Optimism about rate cuts by the Fed and several central banks in Europe is also expected to aid market's rise.
RTTNews | Pred 4 h 24 min
BioNTech Slips To Loss In Q1

BioNTech Slips To Loss In Q1

Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a net loss of 315.1 million euros or 1.31 euros per share for the first quarter, compared to net profit of 502.2 million euros or 2.05 euros per share in the prior-year quarter.
RTTNews | Pred 5 h 26 min
Eurozone Sentix Investor Confidence Rises For 7 Straight Months

Eurozone Sentix Investor Confidence Rises For 7 Straight Months

Eurozone investor confidence improved for the seventh straight month in May to hit the highest level since February 2022 as both current situation and expectations rose in small but steady steps, a closely watched survey showed on Monday. The investor confidence index posted -3.6 in May, the behavioral research institute Sentix reported. The score was forecast to improve moderately to -4.8.
RTTNews | Pred 5 h 35 min